FDA Drug Safety Board Discusses Criteria For Releasing Emerging Safety Info
This article was originally published in The Pink Sheet Daily
Executive Summary
Board considers past actions regarding Shire’s Adderall and erectile dysfunction drugs in attempting to establish method for informing public of safety concerns.